DM
David C. Montefiori

Publications (11)

Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccines
Article scientifique · 2025
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials
Article scientifique · 2024
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials
Article scientifique · 2023
ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection
Article scientifique · 2021
A Population-Based Threshold of Protection for COVID-19 Vaccines
Article scientifique · 2021
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines
Article scientifique · 2020
Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
Article scientifique · 2019
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting
Article scientifique · 2017
Sequential Immunization with gp140 Boosts Immune Responses Primed by Modified Vaccinia Ankara or DNA in HIV-Uninfected South African Participants
Article scientifique · 2016
Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization
Article scientifique · 2016
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection
Article scientifique · 2016

Domaines principaux

Sciences de la santé10

Statistiques

Consultations31
Téléchargements0